These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 26459194)

  • 1. Synthesis and Pharmacological Properties of Silicon-Containing GPR81 and GPR109A Agonists.
    Geyer M; Baus JA; Fjellström O; Wellner E; Gustafsson L; Tacke R
    ChemMedChem; 2015 Dec; 10(12):2063-70. PubMed ID: 26459194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of novel GPR81 agonist lead series for target biology evaluation.
    Davidsson Ö; Nilsson K; Brånalt J; Andersson T; Berggren K; Chen Y; Fjellström O; Gradén H; Gustafsson L; Hermansson NO; Jansen F; Johannesson P; Ohlsson B; Tyrchan C; Wellner A; Wellner E; Ölwegård-Halvarsson M
    Bioorg Med Chem Lett; 2020 Feb; 30(4):126953. PubMed ID: 31932225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpressing cell systems are a competitive option to primary adipocytes when predicting in vivo potency of dual GPR81/GPR109A agonists.
    Almquist J; Hovdal D; Ahlström C; Fjellström O; Gennemark P; Sundqvist M
    Eur J Pharm Sci; 2018 Mar; 114():155-165. PubMed ID: 29180298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a novel GPR81-selective agonist that suppresses lipolysis in mice without cutaneous flushing.
    Sakurai T; Davenport R; Stafford S; Grosse J; Ogawa K; Cameron J; Parton L; Sykes A; Mack S; Bousba S; Parmar A; Harrison D; Dickson L; Leveridge M; Matsui J; Barnes M
    Eur J Pharmacol; 2014 Mar; 727():1-7. PubMed ID: 24486398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sila-haloperidol, a silicon analogue of the dopamine (D2) receptor antagonist haloperidol: synthesis, pharmacological properties, and metabolic fate.
    Tacke R; Popp F; Müller B; Theis B; Burschka C; Hamacher A; Kassack MU; Schepmann D; Wünsch B; Jurva U; Wellner E
    ChemMedChem; 2008 Jan; 3(1):152-64. PubMed ID: 18022977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can silicon make an excellent drug even better? An in vitro and in vivo head-to-head comparison between loperamide and its silicon analogue sila-loperamide.
    Geyer M; Wellner E; Jurva U; Saloman S; Armstrong D; Tacke R
    ChemMedChem; 2015 May; 10(5):911-24. PubMed ID: 25801200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pyrido pyrimidinones as selective agonists of the high affinity niacin receptor GPR109A: optimization of in vitro activity.
    Peters JU; Kühne H; Dehmlow H; Grether U; Conte A; Hainzl D; Hertel C; Kratochwil NA; Otteneder M; Narquizian R; Panousis CG; Ricklin F; Röver S
    Bioorg Med Chem Lett; 2010 Sep; 20(18):5426-30. PubMed ID: 20724150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. International Union of Basic and Clinical Pharmacology. LXXXII: Nomenclature and Classification of Hydroxy-carboxylic Acid Receptors (GPR81, GPR109A, and GPR109B).
    Offermanns S; Colletti SL; Lovenberg TW; Semple G; Wise A; IJzerman AP
    Pharmacol Rev; 2011 Jun; 63(2):269-90. PubMed ID: 21454438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GPR109A, GPR109B and GPR81, a family of hydroxy-carboxylic acid receptors.
    Ahmed K; Tunaru S; Offermanns S
    Trends Pharmacol Sci; 2009 Nov; 30(11):557-62. PubMed ID: 19837462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of rat and dog models of vasodilatation and lipolysis for the calculation of a therapeutic index for GPR109A agonists.
    Carballo-Jane E; Gerckens LS; Luell S; Parlapiano AS; Wolff M; Colletti SL; Tata JR; Taggart AK; Waters MG; Richman JG; McCann ME; Forrest MJ
    J Pharmacol Toxicol Methods; 2007; 56(3):308-16. PubMed ID: 17643322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analogues of acifran: agonists of the high and low affinity niacin receptors, GPR109a and GPR109b.
    Jung JK; Johnson BR; Duong T; Decaire M; Uy J; Gharbaoui T; Boatman PD; Sage CR; Chen R; Richman JG; Connolly DT; Semple G
    J Med Chem; 2007 Apr; 50(7):1445-8. PubMed ID: 17358052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluorinated pyrazole acids are agonists of the high affinity niacin receptor GPR109a.
    Skinner PJ; Cherrier MC; Webb PJ; Shin YJ; Gharbaoui T; Lindstrom A; Hong V; Tamura SY; Dang HT; Pride CC; Chen R; Richman JG; Connolly DT; Semple G
    Bioorg Med Chem Lett; 2007 Oct; 17(20):5620-3. PubMed ID: 17804224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell-surface G-protein-coupled receptors for tumor-associated metabolites: A direct link to mitochondrial dysfunction in cancer.
    Ristic B; Bhutia YD; Ganapathy V
    Biochim Biophys Acta Rev Cancer; 2017 Aug; 1868(1):246-257. PubMed ID: 28512002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro metabolism of haloperidol and sila-haloperidol: new metabolic pathways resulting from carbon/silicon exchange.
    Johansson T; Weidolf L; Popp F; Tacke R; Jurva U
    Drug Metab Dispos; 2010 Jan; 38(1):73-83. PubMed ID: 19812350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Study of GPR81, the lactate receptor, from distant species identifies residues and motifs critical for GPR81 functions.
    Kuei C; Yu J; Zhu J; Wu J; Zhang L; Shih A; Mirzadegan T; Lovenberg T; Liu C
    Mol Pharmacol; 2011 Nov; 80(5):848-58. PubMed ID: 21862690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of Hydroxybenzoic Acids as Selective Lactate Receptor (GPR81) Agonists with Antilipolytic Effects.
    Dvorak CA; Liu C; Shelton J; Kuei C; Sutton SW; Lovenberg TW; Carruthers NI
    ACS Med Chem Lett; 2012 Aug; 3(8):637-9. PubMed ID: 24900524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lactate inhibits lipolysis in fat cells through activation of an orphan G-protein-coupled receptor, GPR81.
    Liu C; Wu J; Zhu J; Kuei C; Yu J; Shelton J; Sutton SW; Li X; Yun SJ; Mirzadegan T; Mazur C; Kamme F; Lovenberg TW
    J Biol Chem; 2009 Jan; 284(5):2811-2822. PubMed ID: 19047060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GPR109a agonists. Part 2: pyrazole-acids as agonists of the human orphan G-protein coupled receptor GPR109a.
    Imbriglio JE; Chang S; Liang R; Raghavan S; Schmidt D; Smenton A; Tria S; Schrader TO; Jung JK; Esser C; Holt TG; Wolff MS; Taggart AK; Cheng K; Carballo-Jane E; Waters MG; Tata JR; Colletti SL
    Bioorg Med Chem Lett; 2010 Aug; 20(15):4472-4. PubMed ID: 20615702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elucidation of signaling and functional activities of an orphan GPCR, GPR81.
    Ge H; Weiszmann J; Reagan JD; Gupte J; Baribault H; Gyuris T; Chen JL; Tian H; Li Y
    J Lipid Res; 2008 Apr; 49(4):797-803. PubMed ID: 18174606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel 3,6,7-substituted pyrazolopyrimidines as positive allosteric modulators for the hydroxycarboxylic acid receptor 2 (GPR109A).
    Blad CC; van Veldhoven JP; Klopman C; Wolfram DR; Brussee J; Lane JR; Ijzerman AP
    J Med Chem; 2012 Apr; 55(7):3563-7. PubMed ID: 22420767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.